Fig. 6. Different integrated optical microfluidic devices for the detection of breast cancer specific biomarkers. (I) Microfluidic device for the detection of circulating CD63 positive exosomes. Reproduced with permission.111 Copyright 2017, PLOS ONE. (II) Immunofluorescence based isolation and detection of the EpCAM expressing exosome. Reproduced with permission.112 Copyright 2019, American Institute of Physics (AIP). (III) Self-competent SERS based sensing platform for the detection of BRCA1 specific peptides. Reproduced with permission.113 Copyright 2014, Royal Society of Chemistry.
